Tirzepatide for treating cannabis use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests whether tirzepatide, a medicine used for type 2 diabetes and weight loss, can help people with severe cannabis use disorder cut down or quit. It may reduce cravings and other symptoms of withdrawal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and speak English.
- You have a diagnosis of severe cannabis use disorder (based on DSM-5).
- You are not currently taking other weight loss or diabetes medications (like Ozempic or similar drugs) in the last 3 months.
- You do not have certain medical conditions like diabetes, eating disorders, recent heart problems, or a history of pancreatitis or gallbladder disease.
- You are not pregnant or breastfeeding, and agree to use contraception if applicable.
- You are not participating in any other drug trial at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether tirzepatide, a medicine used for diabetes and weight loss, can help reduce cannabis use in people with moderate to severe cannabis use disorder. If you qualify, you would take the medicine for a period and track your cannabis use.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
This study tests whether a weekly injection called tirzepatide (a drug used for diabetes and weight loss) can help people reduce their cannabis use. If you're interested in cutting down and have a higher body weight, this trial might offer a new approach.
This trial tests if tirzepatide, a medication that helps with appetite and blood sugar, can help people with alcohol use disorder drink less or stop drinking. You would visit the clinic regularly and receive the drug or a placebo.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This study tests whether tirzepatide, a medication that may help reduce cravings and weight, can help people who use methamphetamine cut down or stop. It aims to find a new treatment option for methamphetamine use disorder.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.